Statements in which the resource exists as a subject.
PredicateObject
rdf:type
skos:definition
"A carboxylic ester resulting from the formal condensation or (S)-2-methylbutyric acid with the hydroxy group adjacent to the ring junction of (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid. Derived from microbial transformation of mevastatin, pravastatin is a reversible inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA). The sodium salt is used for lowering cholesterol and preventing cardiovascular disease. It is one of the lower potency statins, but has the advantage of fewer side effects compared with lovastatin and simvastatin." []
skos:inScheme
skos:prefLabel
pravastatin
skos:altLabel
(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid
skos:notation
ChemIDplus:81093-37-0 "CAS Registry Number", CiteXplore:21749370 "PubMed citation", CiteXplore:21851379 "PubMed citation", DrugBank:DB00175 "DrugBank", HMDB:HMDB05022 "HMDB", KEGG COMPOUND:81093-37-0 "CAS Registry Number", KEGG COMPOUND:C01844 "KEGG COMPOUND", KEGG DRUG:D08410 "KEGG DRUG", Reaxys:4825538 "Reaxys Registry Number", Wikipedia:Pravastatin "Wikipedia"
skos:broader
skos:relatedSynonym
pravastatin, pravastatinum, pravastatin acid, pravastatina, (+)-(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acid, pravastatine, C23H36O7, [H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC, InChI=1S/C23H36O7/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28)/t13-,14-,16+,17+,18+,19-,20-,22-/m0/s1, InChIKey=TUZYXOIXSAXUGO-PZAWKZKUSA-N